万孚生物：不向下修正万孚转债转股价格

Core Points - Wanfu Bio (300482) announced on October 21 that it will not lower the conversion price of its convertible bonds during the upcoming three-month period [1] - The board of directors decided that if the conversion price adjustment clause is triggered again after January 22, 2026, a new meeting will be held to determine whether to exercise the downward adjustment right [1] Summary by Sections - Company Announcement - Wanfu Bio will hold its fifth board meeting on October 21, 2025, to discuss the non-adjustment of the convertible bond conversion price [1] - The company will not propose a downward adjustment for the "Wanfu Convertible Bonds" during the specified three-month period from October 22, 2025, to January 21, 2026 [1] - Future Considerations - If the conversion price adjustment clause is triggered again after January 22, 2026, the board will reconvene to decide on the adjustment [1]